Catalyst Crew Rebrands as LataMed AI in Major Healthcare Tech Pivot

Catalyst Crew Technologies Corp. (OTC: CCTC), a development-stage company, has announced a dramatic pivot in its corporate strategy, filing a Form 8-K with the U.S. Securities and Exchange Commission to disclose a complete shift from its prior business focus. The company is now positioning itself as an artificial intelligence-enabled healthcare technology firm, with an initial focus on Latin America and other emerging markets. This strategic transition involves developing AI-driven healthcare software platforms, telehealth and remote patient monitoring technologies, clinical data analytics systems, and healthcare workflow automation solutions. The company also plans to pursue strategic acquisitions and partnerships within the healthcare technology sector, though it remains in the development stage and cautions that there is no assurance of successful implementation, financing, or revenue generation.

In a significant move to align its corporate identity with its new direction, the company intends to change its name to LataMed AI Corp. This proposed name change will be effected through filing Articles of Amendment with the State of Nevada and is subject to corporate approvals. Furthermore, the company will submit a Company Related Action Notification Form to the Financial Industry Regulatory Authority (FINRA) to request review and processing of both the corporate name change and a corresponding ticker symbol change. It is important to note that neither change will become effective until FINRA completes its review and announces an effective date, and there is no guarantee of approval or timing. Investors can review the full details in the Form 8-K available on the SEC's EDGAR database, and the company encourages interested parties to read the document in its entirety. The original release can be viewed on www.newmediawire.com, where further updates will be provided as the company develops a new corporate website to reflect its updated branding and business direction.

Catalyst Crew Technologies Corp., soon to be LataMed AI Corp., describes itself as an AI-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets. Its mission is to improve access, efficiency, and care coordination through telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms. The company emphasizes that it is a development-stage enterprise that has not yet generated revenues from this new direction and that its securities involve a high degree of risk. It will continue to meet its reporting obligations under the Securities Exchange Act and provide updates through SEC filings and OTC Markets Group. This announcement represents a foundational corporate action rather than commercial deployment, and the company has included extensive forward-looking statements and disclaimers regarding the uncertainties of its strategic transition.